RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 161 filers reported holding RELAY THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.30 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $8,912,312 | +10.2% | 541,124 | 0.0% | 0.94% | -6.6% |
| Q4 2022 | $8,084,393 | -33.2% | 541,124 | 0.0% | 1.00% | -33.5% |
| Q3 2022 | $12,105,000 | +33.6% | 541,124 | 0.0% | 1.51% | +43.6% |
| Q2 2022 | $9,064,000 | -44.0% | 541,124 | 0.0% | 1.05% | -35.8% |
| Q1 2022 | $16,196,000 | -2.5% | 541,124 | 0.0% | 1.64% | +4.8% |
| Q4 2021 | $16,618,000 | -2.6% | 541,124 | 0.0% | 1.56% | +56.0% |
| Q3 2021 | $17,062,000 | -13.8% | 541,124 | 0.0% | 1.00% | -12.2% |
| Q2 2021 | $19,800,000 | +5.8% | 541,124 | 0.0% | 1.14% | +9.0% |
| Q1 2021 | $18,707,000 | -16.8% | 541,124 | 0.0% | 1.04% | -14.3% |
| Q4 2020 | $22,489,000 | -2.4% | 541,124 | 0.0% | 1.22% | -3.7% |
| Q3 2020 | $23,046,000 | – | 541,124 | – | 1.27% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 6,923,574 | $58,227,257 | 6.44% |
| Finepoint Capital LP | 870,870 | $7,324,017 | 3.65% |
| Nextech Invest Ltd. | 1,196,409 | $10,061,800 | 3.05% |
| MPM BioImpact LLC | 1,352,133 | $11,371,439 | 3.04% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $234,680,739 | 1.93% |
| EcoR1 Capital, LLC | 4,163,824 | $35,017,760 | 1.18% |
| Integral Health Asset Management, LLC | 800,000 | $6,728,000 | 0.93% |
| Alphabet Inc. | 1,568,753 | $13,193,212 | 0.85% |
| HARBOURVEST PARTNERS LLC | 296,402 | $2,492,741 | 0.85% |
| Boxer Capital, LLC | 1,819,132 | $15,298,900 | 0.81% |